Amjad Khan
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Potential Adjunctive Effects of Quercetin-Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 04, 2026
Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19.
Journal: Medicina clinica
Published: November 21, 2022
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial.
Journal: Frontiers in pharmacology
Published: November 12, 2022
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19-Results from a pragmatic randomized clinical trial.
Journal: Frontiers in nutrition
Published: August 20, 2022
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.
Journal: Frontiers in pharmacology
Published: March 16, 2022
Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan.
Journal: Therapeutic advances in infectious disease
Published: November 20, 2021
Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID).
Journal: International journal of general medicine
Published: July 30, 2021
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study.
Journal: International journal of general medicine
Published: May 06, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.
Journal: International journal of general medicine
Published: May 06, 2021
Virus-induced senescence is a driver and therapeutic target in COVID-19.
Journal: Nature
Published: January 10, 2021
Impact of lockdown and school closure on children in special schools: a single-centre survey.
Journal: BMJ paediatrics open
Published: December 08, 2020
Quercetin Phytosome® as a potential candidate for managing COVID-19.
Journal: Minerva gastroenterology
Published: October 05, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026